Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Introduction of Executive Officer System and Changes in Directors of the Board
Notice Regarding Selection as a Constituent of the JPX Start-Up Acceleration 100 Index
Presentation material of financial results for the fiscal year ended December 31, 2025 (FY2025)
Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2025
Heartseed, Net Income for The Current Fiscal Year, with a Change in the Fiscal Year-End, is loss of 2.1 Billion Yen
Notice Regarding the Revisions of Full-Year Financial Results Forecastfor the Fiscal Year Ending December 31, 2025
Non-consolidated Financial Results for the Twelve Months Ended October 31, 2025 (Under Japanese GAAP)
Heartseed, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.5 times
Completion of 30-day review for clinical trial notification for Phase I/II study of HS-005 (catheter administration)
Supplemental comments regarding termination of partnership with Novo Nordisk AS (#3)
Notice of submission of clinical trial notification for Phase I/II study of HS-005 targeting severe HF due to IHD and DCM
Supplemental comments regarding termination of partnership with Novo Nordisk AS (#2)
Supplemental comments regarding termination of partnership with Novo Nordisk AS
Notice regarding termination of partnership with Novo Nordisk AS
Heartseed, Nov-Jul (Cumulative 3Q) Ordinary Profit Turns to Profit
Notice regarding the new partner for delivery catheter system for allogeneic iPS cell-derived cardiomyocyte spheroids
Non-consolidated Financial Results for the Nine Months Ended July 31, 2025 (Under Japanese GAAP)
Notice Regarding the Revisions of Full-Year Financial Results Forecast for the Fiscal Year Ending December 31, 2025
Heartseed, Ordinary Profit Forecast for the Fiscal Year Turns to Profit, Exceeds Expectations
Notice Regarding Selection as Loan Margin Trading Isssue